Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionubiquitin protein ligase activity

ASB4 ZNRF3 RNF19A TRIM35 KCMF1

1.79e-04372295GO:0061630
GeneOntologyMolecularFunctiontransition metal ion binding

FLG PRKCG SIRT2 HRNR FLG2 RNF19A TRIM35 KCMF1

2.15e-041189298GO:0046914
GeneOntologyMolecularFunctionubiquitin-like protein ligase activity

ASB4 ZNRF3 RNF19A TRIM35 KCMF1

2.46e-04398295GO:0061659
GeneOntologyMolecularFunctionubiquitin-protein transferase activity

ASB4 ZNRF3 RNF19A TRIM35 KCMF1

5.42e-04473295GO:0004842
GeneOntologyMolecularFunctionacyltransferase activity

ASB4 SIRT2 ZNRF3 RNF19A TRIM35 KCMF1

7.41e-04775296GO:0016746
GeneOntologyMolecularFunctionubiquitin-like protein transferase activity

ASB4 ZNRF3 RNF19A TRIM35 KCMF1

7.76e-04512295GO:0019787
GeneOntologyMolecularFunctionaminoacyltransferase activity

ASB4 ZNRF3 RNF19A TRIM35 KCMF1

9.21e-04532295GO:0016755
GeneOntologyMolecularFunctioncalcium ion binding

FLG CLEC6A HRNR FLG2 TTYH2

4.12e-03749295GO:0005509
GeneOntologyBiologicalProcesspost-translational protein modification

PRKCG ASB4 SIRT2 USP37 ZNRF3 USP15 RNF19A TRIM35 KCMF1

1.94e-051074319GO:0043687
GeneOntologyBiologicalProcessestablishment of skin barrier

FLG HRNR FLG2

3.15e-0541313GO:0061436
GeneOntologyBiologicalProcessprotein modification by small protein conjugation or removal

PRKCG ASB4 USP37 ZNRF3 USP15 RNF19A TRIM35 KCMF1

9.19e-051009318GO:0070647
GeneOntologyCellularComponentkeratohyalin granule

FLG HRNR FLG2

2.95e-085313GO:0036457
GeneOntologyCellularComponentcornified envelope

FLG HRNR FLG2

1.45e-0469313GO:0001533
DomainFilaggrin

FLG FLG2

2.33e-062292IPR003303
DomainS100_CABP

FLG HRNR FLG2

9.60e-0627293PS00303
DomainS_100

FLG HRNR FLG2

9.60e-0627293PF01023
DomainS100_Ca-bd_sub

FLG HRNR FLG2

1.07e-0528293IPR013787
DomainS100/CaBP-9k_CS

FLG HRNR FLG2

1.07e-0528293IPR001751
DomainS_100

FLG HRNR FLG2

1.07e-0528293SM01394
DomainEF_Hand_1_Ca_BS

FLG HRNR FLG2

2.47e-03175293IPR018247
Domainig

KIR2DL5A AGER LILRB4

3.12e-03190293PF00047
DomainImmunoglobulin

KIR2DL5A AGER LILRB4

3.12e-03190293IPR013151
DomainEF_HAND_1

FLG HRNR FLG2

3.81e-03204293PS00018
DomainUSP_CS

USP37 USP15

4.70e-0366292IPR018200
DomainUSP_1

USP37 USP15

5.27e-0370292PS00972
DomainEF_HAND_2

FLG HRNR FLG2

5.38e-03231293PS50222
DomainUCH

USP37 USP15

5.41e-0371292PF00443
DomainUSP_2

USP37 USP15

5.41e-0371292PS00973
DomainEF_hand_dom

FLG HRNR FLG2

5.45e-03232293IPR002048
DomainUSP_3

USP37 USP15

5.56e-0372292PS50235
DomainUSP_dom

USP37 USP15

5.56e-0372292IPR028889
DomainPeptidase_C19_UCH

USP37 USP15

5.56e-0372292IPR001394
DomainIg_2

AGER LILRB4

5.71e-0373292PF13895
DomainZnf_C2H2

HIVEP3 ZNF263 SORBS2 ZNF433 KCMF1

7.37e-03805295IPR007087
Domain-

FLG HRNR FLG2

7.54e-032612931.10.238.10
DomainEF-hand-dom_pair

FLG HRNR FLG2

9.77e-03287293IPR011992
DomainZF_RING_1

ZNRF3 RNF19A TRIM35

1.01e-02291293PS00518
DomainZF_RING_2

ZNRF3 RNF19A TRIM35

1.08e-02298293PS50089
DomainRING

ZNRF3 RNF19A TRIM35

1.15e-02305293SM00184
DomainZnf_RING

ZNRF3 RNF19A TRIM35

1.38e-02326293IPR001841
Pubmed

Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.

FLG HRNR FLG2

7.07e-10332323403047
Pubmed

Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep.

FLG HRNR

8.20e-07232227678121
Pubmed

Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4.

KIR2DL5A KIR2DL5B

8.20e-07232217215859
Pubmed

Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.

KIR2DL5A KIR2DL5B

8.20e-07232212185535
Pubmed

Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.

KIR2DL5A KIR2DL5B

8.20e-07232211086080
Pubmed

Expression of filaggrin-2 protein in the epidermis of human skin diseases: a comparative analysis with filaggrin.

FLG FLG2

8.20e-07232224813994
Pubmed

Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients.

FLG HRNR FLG2

9.30e-072132319601998
Pubmed

GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.

FLG FLG2

2.46e-06332228928464
Pubmed

Promoter variants of KIR2DL5 add to diversity and may impact gene expression.

KIR2DL5A KIR2DL5B

2.46e-06332218461314
Pubmed

Filaggrin and filaggrin 2 processing are linked together through skin aspartic acid protease activation.

FLG FLG2

2.46e-06332232437351
Pubmed

Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections.

KIR2DL5A KIR2DL5B

4.92e-06432222652695
Pubmed

KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains.

KIR2DL5A KIR2DL5B

4.92e-06432210820258
Pubmed

Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5.

KIR2DL5A KIR2DL5B

4.92e-06432218498296
Pubmed

Expression of Cornified Envelope Proteins in Skin and Its Relationship with Atopic Dermatitis Phenotype.

FLG FLG2

1.23e-05632227304082
Pubmed

USP37 Deubiquitinates CDC73 in HPT-JT Syndrome.

USP37 USP15

1.23e-05632235742816
Pubmed

Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity.

PRKCG SIRT2 SERBP1 PHACTR1

1.62e-0516632427160897
Pubmed

CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway.

FLG SERBP1 FLG2

4.04e-057232336123327
Pubmed

A functional reference map of the RNF8 interactome in cancer.

FLG SERBP1 HRNR FLG2

4.71e-0521832435831895
Pubmed

LncRNA SAMD12-AS1 promotes cell proliferation and inhibits apoptosis by interacting with NPM1.

FLG HRNR

5.38e-051232231406141
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DL5A KIR2DL5B

6.36e-051332219120281
Pubmed

SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.

FLG SERBP1 HRNR FLG2

7.40e-0524532435652658
Pubmed

PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78.

FLG HRNR

7.41e-051432229178343
Pubmed

TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.

FLG HRNR FLG2

8.13e-059132334445801
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DL5A KIR2DL5B

9.76e-051632216403292
Pubmed

TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.

HRNR FLG2

9.76e-051632231823782
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DL5A KIR2DL5B

1.11e-041732219218127
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DL5A KIR2DL5B

1.11e-041732220878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DL5A KIR2DL5B

1.11e-041732220650299
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DL5A KIR2DL5B

1.11e-041732219450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DL5A KIR2DL5B

1.11e-041732219761533
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DL5A KIR2DL5B

1.24e-041832220200544
Pubmed

KAP1 Recruitment of the 7SK snRNP Complex to Promoters Enables Transcription Elongation by RNA Polymerase II.

FLG SERBP1 HRNR FLG2

1.26e-0428132426725010
Pubmed

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.

FLG SERBP1 HRNR FLG2 USP15

1.47e-0455832527591049
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DL5A KIR2DL5B

1.54e-042032220426625
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DL5A KIR2DL5B

1.54e-042032220193031
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DL5A KIR2DL5B

1.87e-042232220492596
Pubmed

Kir2.1 Interaction with Stk38 Promotes Invasion and Metastasis of Human Gastric Cancer by Enhancing MEKK2-MEK1/2-ERK1/2 Signaling.

FLG2 USP15

1.87e-042232229549164
Pubmed

hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.

FLG SERBP1 HRNR FLG2

2.78e-0434632425324306
Pubmed

In Vitro Identification of Histatin 5 Salivary Complexes.

FLG HRNR

2.84e-042732226544073
Pubmed

Interaction network of human early embryonic transcription factors.

ZNF263 HRNR FLG2 DUXB

2.93e-0435132438297188
Pubmed

Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.

LAMC2 AGER

3.05e-042832218593464
Pubmed

Cerebellar development transcriptome database (CDT-DB): profiling of spatio-temporal gene expression during the postnatal development of mouse cerebellum.

PRKCG KCMF1

3.51e-043032218603407
Pubmed

Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.

SERBP1 HRNR

4.00e-043232236252997
Pubmed

TRIM21 ameliorates hepatic glucose and lipid metabolic disorders in type 2 diabetes mellitus by ubiquitination of PEPCK1 and FASN.

FLG SERBP1 HRNR FLG2

4.04e-0438232437249651
Pubmed

Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.

USP37 USP15

4.25e-043332230323974
Pubmed

Aerobic glycolysis tunes YAP/TAZ transcriptional activity.

HRNR FLG2 USP15

4.46e-0416232325796446
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DL5A KIR2DL5B

4.79e-043532219683555
Pubmed

Thioredoxin interacting protein (Txnip) forms redox sensitive high molecular weight nucleoprotein complexes.

FLG HRNR

5.07e-043632231669268
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

FRMD4A PRKCG SORBS2 SERBP1 USP15 PHACTR1

5.32e-04113932636417873
Pubmed

Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1.

HRNR FLG2

7.57e-044432231273033
Cytoband1q21.3

FLG HRNR FLG2

7.58e-051173231q21.3
Cytoband19q13.4

PRKCG LILRB4

1.40e-037932219q13.4
CytobandEnsembl 112 genes in cytogenetic band chr1q21

FLG HRNR FLG2

2.78e-03404323chr1q21
GeneFamilyEF-hand domain containing|S100 fused type protein family

FLG HRNR FLG2

8.14e-0872531350
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DL5A KIR2DL5B

2.77e-0418252620
GeneFamilyUbiquitin specific peptidases

USP37 USP15

2.70e-0356252366
GeneFamilyEF-hand domain containing

FLG HRNR FLG2

3.31e-03219253863
GeneFamilyRing finger proteins

ZNRF3 RNF19A TRIM35

6.25e-0327525358
ToppCelldroplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FRMD4A CLEC6A LILRB4 TTYH2

5.73e-06176304e74ad0db3b05897edcfabeb11008ede2b9eeb638
ToppCelldroplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FRMD4A CLEC6A LILRB4 TTYH2

5.86e-0617730471919b5c9bfa87fdd2cd44dfa057b66ea081be5d
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MALRD1 LILRB4 PHACTR1

1.08e-04138303c172880eda7b8b8b758dbbc77f93191238f3181c
ToppCell368C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

USP37 TRIM35 AGER

1.10e-041393034efab4421e3448880a1dcf981f6a65131b038010
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MALRD1 LILRB4 PHACTR1

1.10e-04139303313f7e66ed94950129c7146a2afe2feb8951fe1e
ToppCell368C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

USP37 TRIM35 AGER

1.10e-0413930339f3c28f89c37bb8cc049c56d2948ea906fb3d86
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP3 CLEC6A LILRB4

1.46e-04153303e426db29e4ba83e7930dc88c74fc975b177c9540
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP3 CLEC6A LILRB4

1.46e-04153303668eacd76aad6054bd7d57e3af0b122c2443465f
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP3 CLEC6A LILRB4

1.46e-041533034b999892fb797e9f0d391630094f466463299d57
ToppCellLPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMC2 MALRD1 CLEC6A

1.52e-041553034559e3011514041b65c17ae4ede29da202bce14c
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ASB4 MALRD1 PHACTR1

1.64e-04159303e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SARAF RNF19A TRIM35

1.67e-041603036b5b5aa12f0d00757728f5597f569d68406d6f56
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

HIVEP3 LAMC2 FLG2

1.73e-04162303373513f9d0e5007b2e10a8b78d4909dcce9e3b62
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FRMD4A LILRB4 PHACTR1

1.76e-04163303a6e272e043859858084b8d4d96fa4ff9e6eca454
ToppCelldroplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ASB4 CLEC6A LILRB4

1.89e-04167303589c0acfeb4d70931b6726fb3331d85a54e74d56
ToppCellcontrol-Myeloid-Monocyte-derived_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LILRB4 TTYH2 PHACTR1

2.03e-04171303e828b684744a4fdf6b63ec033c4f000b39ca0d51
ToppCellAT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id

LAMC2 RNF19A AGER

2.10e-04173303b29816427428c7053017477f59b828bf1357f3b2
ToppCellNS-control-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LILRB4 TTYH2 PHACTR1

2.14e-04174303758984730cd1c3ccf6866a3a8f03d6e002f3edb6
ToppCellTCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9

CT62 LAMC2 LILRB4

2.14e-0417430396f1d025af3a5bf616926a558885d196c3cd2709
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMC2 ZNRF3 AGER

2.14e-04174303d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCellmild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2)

MALRD1 FLG2 LILRB4

2.17e-04175303b87f279a7519710146c49d6acccb0adedc195965
ToppCellP03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LAMC2 AGER PHACTR1

2.21e-04176303f3a54038cde58326f1caed96ecca33c141bcc8b3
ToppCelldroplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMC2 ZNRF3 PHACTR1

2.21e-04176303533d544852038c0612aacf87f4b1c88ff7aace82
ToppCellCOVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations)

LAMC2 AGER PHACTR1

2.32e-04179303a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMC2 SORBS2 AGER

2.32e-0417930304ce3673e46606f63d9c87bcba3a64c96817d812
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

LAMC2 AGER PHACTR1

2.32e-041793034f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CLEC6A LILRB4 PHACTR1

2.40e-0418130308bc6fe2a11d31a7e5e4a4552b04c0ebc2aefc59
ToppCellPND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMC2 AGER PHACTR1

2.44e-04182303573771130247e869e4e58f22d4a1cb31989635cf
ToppCellE12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LAMC2 SORBS2 AGER

2.44e-04182303204530444e35d4977a7239ac176f477e9e5c29ab
ToppCellPND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMC2 AGER PHACTR1

2.44e-041823036cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCellCOVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type

LAMC2 AGER PHACTR1

2.48e-04183303942530449e9c6583705eeb8f6f12621daea57252
ToppCellfacs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASB4 SORBS2 RNF19A

2.48e-0418330312e876d6205af8aad74265c668b5e95b9e7487f3
ToppCellCOVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type

LAMC2 AGER PHACTR1

2.48e-041833037b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

SORBS2 ZNRF3 PHACTR1

2.48e-041833036847c1252d6bb105524f812658112517fd351eab
ToppCelldroplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRMD4A CLEC6A TTYH2

2.48e-04183303ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LAMC2 AGER PHACTR1

2.52e-0418430329c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCelldroplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRMD4A CLEC6A TTYH2

2.52e-041843033261d767d5e3d9e9fbac22ad73ca14e44beed89c
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor

LAMC2 AGER PHACTR1

2.56e-041853031c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRMD4A CLEC6A TTYH2

2.56e-04185303afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRMD4A CLEC6A TTYH2

2.56e-04185303775b72319ef6acffd2c9a74293b9c1bccea33f42
ToppCell10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FRMD4A USP15 RNF19A

2.56e-04185303e9059cefcdf0972ec90793b1dd34c3292b17a061
ToppCellEpithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor

LAMC2 AGER PHACTR1

2.60e-0418630309d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMC2 SORBS2 ZNRF3

2.60e-041863034e94158db52df41d71e67b02b9895a358eebee0f
ToppCelldroplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRMD4A CLEC6A TTYH2

2.64e-04187303f20e7a1751694390f535ffb27b97e887220f8695
ToppCellE12.5-Epithelial-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

LAMC2 SORBS2 AGER

2.64e-04187303ab6f4d387218b4651fdadbf269806c1ddc96a1d2
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LAMC2 ZNRF3 AGER

2.64e-0418730358d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCelldroplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FRMD4A CLEC6A TTYH2

2.64e-04187303f0c6e53035b00772377c4d5f761b4d11026b911a
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FRMD4A LILRB4 PHACTR1

2.64e-0418730398026c1aaf8de280470ad75536121357934fc78d
ToppCellILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

FRMD4A USP15 PHACTR1

2.64e-041873030099def970fbc828756fbf853eca2ce77b8cd342
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LAMC2 AGER PHACTR1

2.64e-041873034ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCellPND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CLEC6A AGER LILRB4

2.64e-04187303b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor

LAMC2 AGER PHACTR1

2.64e-0418730377f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

LAMC2 SORBS2 PHACTR1

2.64e-041873038e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f
ToppCell10x5'-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue

CLEC6A LILRB4 PHACTR1

2.64e-04187303ab9c9930341527122f26fe5544c5c4818d1fd1b5
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CLEC6A LILRB4 PHACTR1

2.68e-04188303c7c2cf1aa328e735073d6031e44b5dbd55beae6d
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SARAF RNF19A TRIM35

2.68e-0418830376f9b4276455026537a62b0e6d4883ddb68f38ba
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LAMC2 AGER PHACTR1

2.68e-04188303eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCellRV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper

SORBS2 USP37 PHACTR1

2.77e-0419030393c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCellChildren_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

SORBS2 ZNRF3 PHACTR1

2.81e-04191303e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor

SORBS2 ZNRF3 PHACTR1

2.81e-04191303a0332a4ef629510fb313ec119195c44a3f704a80
ToppCellEpithelial|World / Lineage, Cell type, age group and donor

SORBS2 ZNRF3 PHACTR1

2.85e-04192303499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue

SARAF USP15 RNF19A

2.85e-0419230304bd6e135733570e877af9460f87379ed0a5c5f8
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMC2 AGER PHACTR1

2.85e-04192303790282d4232311df3dac4ad97c80fc53443beccc
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMC2 AGER PHACTR1

2.85e-04192303b2d9bffccd6264b4f12d88a0780646ee0b41969f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

HIVEP3 LAMC2 PHACTR1

2.90e-0419330380e058c224749b5fe0ba3e944b48317c2371cb63
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

HIVEP3 LAMC2 PHACTR1

2.90e-04193303b991fbbb4618401624f0b3045f0e81a606d3a763
ToppCelldroplet-Kidney-nan-3m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMC2 SORBS2 PHACTR1

2.90e-04193303536b277d90070c4571c592a3c6323b4bf4819f67
ToppCelldroplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMC2 SORBS2 PHACTR1

2.90e-041933030499611c21d283321ef6dd24add154dea48da1b7
ToppCellwk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

FRMD4A USP15 RNF19A

2.90e-04193303be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCellCOVID-19_Mild|World / Disease condition and Cell class

SARAF USP15 RNF19A

2.90e-041933037256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FRMD4A LILRB4 TTYH2

2.94e-041943037c7091de47359760003e910cfbe63db5c99410d6
ToppCell10x5'-Liver-Myeloid_Dendritic|Liver / Manually curated celltypes from each tissue

LILRB4 TTYH2 PHACTR1

2.94e-04194303e6391bc7073831847c469ef0b0c437118e1f151f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FRMD4A LILRB4 PHACTR1

2.94e-0419430345708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FRMD4A LILRB4 PHACTR1

2.99e-04195303247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FRMD4A LILRB4 PHACTR1

2.99e-04195303562e4c0e4e81f6303e57b846da71d1667fc35963
ToppCellBronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LAMC2 AGER PHACTR1

2.99e-04195303a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FRMD4A LILRB4 PHACTR1

2.99e-04195303fa8ac154e5aebc26463ff84f0ad1038095770bc6
ToppCellcontrol-Myeloid-Non-resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

LILRB4 TTYH2 PHACTR1

3.03e-04196303646a8d47dddffdfd2d8a62245ea6cd49f9510a1a
ToppCell343B-Myeloid-Dendritic|343B / Donor, Lineage, Cell class and subclass (all cells)

FAM111B LILRB4 PHACTR1

3.03e-04196303fdb4f7e757b30b974ed3cd80c47beb4557a70845
ToppCellCOVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type

HIVEP3 LAMC2 PHACTR1

3.03e-0419630304f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-GC_B_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HIVEP3 SERBP1 PHACTR1

3.03e-04196303d08f6143d148a897efacc854e4306455a9a9868c
ToppCellMid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FRMD4A SORBS2 PHACTR1

3.03e-04196303676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMC2 AGER PHACTR1

3.03e-041963039790340c25f446ec655f5a0b64ec3bb44ed2e1bd
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMC2 AGER PHACTR1

3.03e-04196303b9ceceeacbcf81976ce92adf044f0d0aa132632b
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster

FRMD4A SORBS2 TTYH2

3.03e-0419630338da0751941adca650fe9b383d9f343153978eb5
ToppCellAT1|World / shred by cell class for parenchyma

LAMC2 AGER FAM111B

3.03e-041963032bc487f8a109a6961ebff111dec79c2227ea60ac
ToppCell10x3'2.3-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

FRMD4A USP15 RNF19A

3.03e-0419630351c48944149a89b98011a50fe81ca6664d5f0d44
ToppCellControl-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

HIVEP3 SARAF PHACTR1

3.03e-0419630354074da84000e4749ade8acc542f05a275bf829f
ToppCellMonocytes-IL1B+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

FRMD4A LILRB4 PHACTR1

3.03e-041963037bc0735d324ac5a1661434cda4116ddd58296730
ToppCellEpithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4)

LAMC2 AGER PHACTR1

3.03e-0419630341b21a18125cc95bc8adde3369e4abd029cf137d
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster

FRMD4A SORBS2 TTYH2

3.03e-04196303721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell10x5'v1-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

FRMD4A USP15 RNF19A

3.08e-04197303d8f99a9f2367c8bc9308b0c64d0226875262927a
ToppCellmyeloid-pro-pDC|World / Lineage and Cell class

FAM111B LILRB4 PHACTR1

3.08e-041973038918ee006b16f6b86ed33ce1dd5c0f01f51f88f5
ToppCellPND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMC2 AGER PHACTR1

3.08e-04197303bbb7c106d5b96b8e95aeb3e5c293e104fceea234
ToppCellNS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LILRB4 TTYH2 PHACTR1

3.08e-04197303496a1115071a1be6928786192de49f3adf197dfb
ToppCellPND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

LAMC2 AGER PHACTR1

3.08e-04197303b0fb5774525ba05f60c635d42f14bb8d79bff17c
ToppCellTCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

SARAF USP37 LILRB4

3.12e-04198303af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCellSomatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

FRMD4A SORBS2 PHACTR1

3.12e-04198303c01091ef18e096d792ea2a7a715764a5b215355f
ToppCellNS-control-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

LILRB4 TTYH2 PHACTR1

3.12e-04198303846852943a8ff60f746fd49498240e25ca1c1b09
ToppCellsevere-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

HRNR LILRB4 PHACTR1

3.12e-0419830322da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6
Diseasecortical surface area change measurement, age at assessment

USP15 PHACTR1

1.58e-0419292EFO_0008007, EFO_0021503
Diseasevaline measurement

MALRD1 USP15

7.11e-0440292EFO_0009792
DiseaseDrug-induced agranulocytosis, response to clozapine

AGER LILRB4

7.84e-0442292GO_0097338, HP_0012235
DiseaseAlzheimer's disease (implicated_via_orthology)

HIVEP3 AGER

1.44e-0357292DOID:10652 (implicated_via_orthology)
Diseasenon-lobar intracerebral hemorrhage

FRMD4A ZNRF3

1.76e-0363292EFO_0010178
DiseaseMechanical Allodynia

PRKCG AGER

3.09e-0384292C2936719
DiseaseHyperalgesia

PRKCG AGER

3.09e-0384292C0020429
DiseaseAllodynia

PRKCG AGER

3.09e-0384292C0458247
DiseaseHyperalgesia, Secondary

PRKCG AGER

3.09e-0384292C0751212
DiseaseHyperalgesia, Primary

PRKCG AGER

3.09e-0384292C0751211
DiseaseHyperalgesia, Thermal

PRKCG AGER

3.09e-0384292C0751214
DiseaseTactile Allodynia

PRKCG AGER

3.09e-0384292C0751213
Diseaselifestyle measurement, depressive symptom measurement

FRMD4A PHACTR1

4.78e-03105292EFO_0007006, EFO_0010724

Protein segments in the cluster

PeptideGeneStartEntry
YSLSGHTALHFCTTP

ASB4

136

Q9Y574
TSGHSGSFLYQVSTH

FLG

2731

P20930
QGTYSCVATHSSHGP

AGER

296

Q15109
THGGTYTCFGSLHDS

KIR2DL5A

186

Q8N109
HSGSDRSSFSHYSGL

SERBP1

196

Q8NC51
HEYGSCGRFSNSSSS

FLG2

396

Q5D862
SGHSEYSDSEGHSGF

FLG2

1801

Q5D862
SEYSDSEGHSGVSHT

FLG2

2031

Q5D862
TSVHGGTYRCFSSHG

LILRB4

186

Q8NHJ6
THGGTYTCFSSLHDS

KIR2DL5B

186

Q8NHK3
YSSGFGHHESSSEHS

HRNR

461

Q86YZ3
SSSCGHYESGSGQAS

HRNR

801

Q86YZ3
HSYSSPTFCDHCGSL

PRKCG

106

P05129
CSTSYHSSGLHSGDG

PHACTR1

336

Q9C0D0
EAHCAHYTSTTGSCN

MALRD1

1716

Q5VYJ5
DCSSCTSHSSSEHYY

FRMD4A

746

Q9P2Q2
HLSSHAQYSCFSSAT

COLCA2

86

A8K830
HYFSCSHSSSGHETL

DUXB

196

A0A1W2PPF3
CYESGATTTRHTTDH

KCMF1

36

Q9P0J7
GHSASCRSSAEYSVH

LAMC2

191

Q13753
AYSHTHRTFSHFSCG

CT62

21

P0C5K7
THTLSYDTCFSDGSS

FAM111B

636

Q6SJ93
AEGHSHSCYHDTRSG

TRIM35

381

Q9UPQ4
HGGSGSYSVCSNSDT

SARAF

311

Q96BY9
STATGLHYSVPSCHY

POU1F1

46

P28069
AHGTFYTSHCVSASC

SIRT2

186

Q8IXJ6
HFSFTSSESFYGSSH

SORBS2

626

O94875
ELHSYHSSLTCFSEG

CLEC6A

56

Q6EIG7
TSCSHGSSDYHTRFA

RNF19A

741

Q9NV58
HSFCSYSSGLGSQTS

TTYH2

451

Q9BSA4
LYSSGSHSSSHERCS

HIVEP3

311

Q5T1R4
RHSSYTHHTGSSLFG

USP15

576

Q9Y4E8
SHIGSTSSSGHYISD

USP37

896

Q86T82
LESGSTSSFSCYHGH

ZNRF3

521

Q9ULT6
TSSFSCYHGHRSVCS

ZNRF3

526

Q9ULT6
NCSSSFRYHGRTHTG

ZNF433

516

Q8N7K0
YTCHECGDSFSHSSN

ZNF263

631

O14978